Nimi Chhina is head of global R&D and regulatory policy at BioMarin Pharmaceutical. She also currently serves as vice-chair of the U.S. regulatory advisory group of the Alliance for Regenerative Medicine (ARM). Prior to joining BioMarin in 2017, Nimi spent 7 years at the FDA, where she served in multiple roles including as team lead in CDER’s Division of Medical Policy Development.